FYI: Fees are no friend to fund investors.
Over the long term, fees are among the best predictors performance, according to Morningstar. That means paying up for a stock picker is going to leave you fighting uphill from the get go.
Greg Carlson, Morningstar’s senior analyst covering equity strategies on the manager research team, finds just four — count ‘em — funds that charge above-average fees but still attain the research firm’s highest rating.
Regards,
Ted
http://blogs.barrons.com/focusonfunds/2015/05/04/4-pricier-funds-that-are-worth-their-salt/tab/print/
Comments
Moreover his 08-09 performance was famously worse than others, causing large abandonment.
Regards,
Ted
http://online.barrons.com/public/fund/snapshot.html?symbol=WPVLX
Here is a Lipper Snapshot of WPVLX ,YAFFX &GABEX comparing total return:
http://www.marketwatch.com/tools/mutual-fund/compare?Tickers=WPVLX+YAFFX+GABEX&Compare=Returns
3/2000: WPVLX's bet on financial may be worth the short-term pain it is causing.
6&7/2001: We think that this is the kind of fund to buy and put away for years.
11/2001: This could be a buying opportunity.
2/2002: This fund's strict attention to value has paid off over the long haul.
4,6,&10/2002: Despite its struggles, WPVLX is worth keeping.
1&2/2003: Better than it looks right now.
7/2003: Investors in this offering have long been rewarded for patience.
12/2003: This fund is worth waiting for.
3/2005: Is this glass half full, or half empty? -and- Not for everyone.
9/2005: We still think there's good reason to like this mutual fund.
5/2006: Despite a very tough year and a half, we thing this mutual fund still has the goods.
12/2007 & 1/2008: This fund fund is down but definitely not out.
6/2008: Be patient with this fund.
11/2008: Recent performance woes don't dim our support for this mutual fund.
4/2009: Investors should stick with this fine mutual fund.
9/2013: Take a bow, Wally Weitz et al. -
the analysis says: "this fund has never been better than duringthe past 4.5 years." After which it wound up in the 63rd percentile for all of 2013 (meaning it had a dreadful latter part of the year) and 82nd percentile for 2014.
Briefly on costs. The M* article concedes that ARTKX's cost is not above average, but they wish it were lower given the large size of the fund. But the article wasn't about sizes of funds, it was about costs, and ARTKX isn't challenged by a high cost.